NMP’s expertise can assist three groups of clients in the healthy longevity space – clinics, technology providers and health systems and organisations.
1Longevity Technology Transfer and Commercialisation
The success of technology transfer and commercialisation hinges on product life cycle management during the phase between R&D and the beginning of formal new product development. We can help to navigate these the initial stages and steer a technology or an early-stage solution through challenges caused by the lack of resources (financial, market and regulatory research, key personnel, etc) as well as conduct marketing activities designed to communicate a value proposition to potential resource providers.
Appraisal of longevity technologies for investment or development
Early-stage technology assessments of health care financing scenarios based on established Health Technology Assessment (HTA) models
Positioning of a novel technology in longevity space
Detailed analysis of the applications, competitive forces, opportunities and threats for actionable customer segmentation and specific value propositions
Business plan development
Business plan development for longevity technologies to ensure maximum return on investment for technology owner
Strategic partnerships for longevity technologies
Strategic partner searches and technology brokering services for the early-stage technologies within longevity medicine sector
Longevity technological assets / IP valuation
Technological and/or IP assets valuation in cases where there is no history of financial relationships, and the prediction of financial results is challenging
Fundraising strategy
Establishing the funding requirements, map funding sources, from government grants to venture financing, and advise on funding applications and/or investment deck
Targeted support for research groups
Detailed assessments based on development benchmarks, cost analysis, comparison to technologies within the same sector and class, and commercialisation options analysis to release maximum value to the technology owner
2Health System Optimisation for Healthy Longevity
The shift from dealing with disease to promoting prevention is vital for the sustainability of health systems worldwide, but this shift poses many challenges that we can assist with:
National, provider and payer strategies for healthy longevity
Strategy development including incentives review, reimbursement and payment models, product positioning, resource requirements and tools for patient and citizen engagement
Technology transfer and development support
Facilitating partnerships between researchers and healthcare providers to commercialise and implement technologies that support healthy longevity
Applications of AI in ‘precision prevention’
Providing support by (a) analysing the population for early intervention, and (b) developing AI-based tools to drive more personalised decision making
Translation of preventative healthcare technologies into clinical practice
Development of strategies to engage clinicians, adapt pathways of care and inform and energise patients to increase adoption
3Healthspan / Longevity Clinic Advisory Services
Clinics fall broadly into two groups: (1) newly established and (2) under conversion from (for example) aesthetic clinics) into healthy longevity-focused establishments. Each service can be separately priced and delivered, although some are dependent on others being completed. Our services are modular, arranged to be matched to a specific clinic situation and status:
Product/service line strategy
Defining the services most appropriate to the target clientele (past and future), their financial appetite and their goals, in terms of health and physical performance
Equipment, capacity planning and utilisation management
Depending on the service lines offered, sourcing equipment and suppliers and putting the systems in place to manage capacity and maximise utilisation
Marketing and client acquisition/ retention strategy
Marketing, branding, pricing and client communications aimed at maximising reach, penetration and profitability in the target group(s)
Regulatory requirements
Identifying the necessary regulatory approvals needed for the services selected, and providing advice on applications and compliance
Protocol Development & Operational Planning
Laying out the workflow and operations management needs for efficient delivery
Business plan development and funding
Creating a rigorous business plan for presentation to potential funders
Each service can be separately priced and delivered, although some are dependent on others being completed.